Kalium Health

Kalium Health is a medical technology company that develops electrolyte sensing devices for patient-centric cardiorenal care. The company was co-founded by CEO Tom Collings and Chief Medical Officer Professor Fiona Karet, spinning out of the University of Cambridge in 2019. The idea originated from Professor Karet’s clinical patients who sought a way to better manage their electrolyte imbalances themselves.

The company's core product is a personalised, digital monitor for blood potassium concentration, which allows for rapid testing from a single drop of blood. This technology aims to provide patients with chronic kidney and heart disease the ability to monitor their blood potassium levels at home, empowering them to manage their conditions between hospital visits and seek timely treatment. The system includes a handheld monitor, a smart patient app, and a HIPAA/GDPR-compliant digital health platform that can integrate with existing electronic health records for real-time data access. This approach is designed to improve health outcomes and reduce healthcare costs associated with managing at-risk patients.

Kalium Health operates in the MedTech and digital health sectors, targeting the multi-billion dollar market for kidney disease and heart failure management. Its business model involves developing and commercializing its sensing technology, supported by a portfolio of intellectual property. The company has secured funding through multiple investment rounds, with backers including Cambridge Enterprise, Kidney Research UK, Martlet Capital, and Cambridge Angels. These funds are being used to advance the core technology, expand R&D facilities, and pursue worldwide partnership opportunities ahead of commercialization.

Keywords: blood potassium monitoring, electrolyte sensing, cardiorenal disease management, kidney disease, heart disease, digital health, MedTech, remote patient monitoring, medical device, patient-centric care, home diagnostics, electrolyte imbalance, nephrology, chronic disease management, Cambridge startup, clinical evaluation, digital monitoring, real-time health data, finger-prick blood test, personalized healthcare